|The KRT17 krt17 (Catalog #MBS2090671) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Monoclonal Antibody to Keratin 17 (KRT17) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Keratin 17 (KRT17) can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP).
Western blotting: 0.2-2ug/mL;1:500-5000
Optimal working dilutions must be determined by end user.
. Researchers should empirically determine the suitability of the KRT17 krt17 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The KRT17 krt17 product has the following accession number(s) (GI #4557701) (NCBI Accession #NP_000413.1) (Uniprot Accession #Q04695). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Monoclonal Antibody to Keratin 17 (KRT17) with the following immunoassay(s):
Western Blot (WB) ((Figure. Western Blot; Sample: Recombinant protein.))
Immunogen: Recombinant Keratin 17 (KRT17). Buffer Formulation: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing KRT17 are readily searchable from our website. Different antibodies against the same target such as KRT17 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Adenocarcinoma, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Esophageal Squamous Cell Carcinoma, Neoplasms, Pachyonychia congenita Jackson Lawler type, Pain, Precancerous Conditions, Skin Neoplasms are some of the diseases may be linked to Monoclonal Antibody to Keratin 17 (KRT17). Bladder, Intestine, Lymph, Lymph Node, Mammary Gland, Mouth, Muscle, Pancreas, Prostate, Skin tissues are correlated with this protein. KRT17 also interacts with the following gene(s): KRT6A, KRT7. The following patways have been known to be associated with this gene.